{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:12:57Z","timestamp":1781863977147,"version":"3.54.5"},"reference-count":419,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["1903324"],"award-info":[{"award-number":["1903324"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014570","name":"Khon Kean University","doi-asserted-by":"publisher","award":["R.G.P.2\/555\/44"],"award-info":[{"award-number":["R.G.P.2\/555\/44"]}],"id":[{"id":"10.13039\/501100014570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014570","name":"Khon Kean University","doi-asserted-by":"publisher","award":["R.G.P.2\/591\/44"],"award-info":[{"award-number":["R.G.P.2\/591\/44"]}],"id":[{"id":"10.13039\/501100014570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","award":["DBT-RA\/2023\/July\/NE\/4835"],"award-info":[{"award-number":["DBT-RA\/2023\/July\/NE\/4835"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/413\/45"],"award-info":[{"award-number":["RGP2\/413\/45"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.canlet.2024.217324","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T21:29:22Z","timestamp":1732051762000},"page":"217324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exploring bile acid transporters as key players in cancer development and treatment: Evidence from preclinical and clinical studies"],"prefix":"10.1016","volume":"609","author":[{"given":"Bintee","family":"Bintee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchira","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravichandran","family":"Vishwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athba","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Rangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-8475","authenticated-orcid":false,"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaikumar B.","family":"Kunnumakkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.217324_bib1","series-title":"Textbook of Biochemistry for Medical Students","author":"Vasudevan","year":"2013"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2183\/pjab.86.484","article-title":"A historical perspective on the discovery of statins","volume":"86","author":"Endo","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"24","key":"10.1016\/j.canlet.2024.217324_bib3","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.3748\/wjg.v21.i24.7436","article-title":"Inhibition of ileal bile acid transporter: an emerging therapeutic strategy for chronic idiopathic constipation","volume":"21","author":"Mosinska","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.biocel.2013.04.012","article-title":"Transport and biological activities of bile acids","volume":"45","author":"Zwicker","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2533\/chimia.2022.1025","article-title":"Transporters for bile formation in physiology and pathophysiology","volume":"76","author":"Stieger","year":"2022","journal-title":"Chimia"},{"key":"10.1016\/j.canlet.2024.217324_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-60761-688-7_22","article-title":"The use of human hepatocytes to investigate bile acid synthesis","volume":"640","author":"Ellis","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib7","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1194\/jlr.R900009-JLR200","article-title":"Bile acids: the role of peroxisomes","volume":"50","author":"Ferdinandusse","year":"2009","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib8","doi-asserted-by":"crossref","first-page":"G537","DOI":"10.1152\/ajpgi.00311.2017","article-title":"Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries","volume":"314","author":"Wei","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Rezen","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1084\/jem.98.2.107","article-title":"Observations concerning the production and excretion of cholesterol in mammals. X. Factors affecting the absorption and fate of ingested cholesterol","volume":"98","author":"Friedman","year":"1953","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(19)32919-1","article-title":"Fat absorption after infusing bile salts into the human small intestine","volume":"67","author":"Shimoda","year":"1974","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2024.217324_bib12","unstructured":"Bank D. Cholic acid: Drug Bank Online; [Available from: https:\/\/go.drugbank.com\/drugs\/DB02659."},{"key":"10.1016\/j.canlet.2024.217324_bib13","unstructured":"Bank D. Deoxycholic acid: Drug Bank Online; [cited March 2024. Available from: https:\/\/go.drugbank.com\/drugs\/DB03619."},{"key":"10.1016\/j.canlet.2024.217324_bib14","unstructured":"Bank D. Taurocholic acid: Drug Bank Online; [Available from: https:\/\/go.drugbank.com\/drugs\/DB04348."},{"key":"10.1016\/j.canlet.2024.217324_bib15","unstructured":"Bank D. Glycochenodeoxycholic acid: Drug Bank Online; [Available from: https:\/\/go.drugbank.com\/drugs\/DB02123."},{"key":"10.1016\/j.canlet.2024.217324_bib16","unstructured":"PubChem. Glycodeoxycholic acid: PubChem NCBI Online; [Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Glycodeoxycholic-acid."},{"key":"10.1016\/j.canlet.2024.217324_bib17","unstructured":"PubChem. Taurodeoxycholic acid: PubChem NCBI Online; [Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2733768."},{"key":"10.1016\/j.canlet.2024.217324_bib18","unstructured":"PubChem. Taurolithocholic acid: PubChem NCBI Online; [Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/439763."},{"key":"10.1016\/j.canlet.2024.217324_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.954090","article-title":"Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer's dementia","volume":"14","author":"Amick","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/nu16020250","article-title":"Gender-specific bile acid profiles in non-alcoholic fatty liver disease","volume":"16","author":"Fitzinger","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.31652","article-title":"Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic Decompensation","volume":"74","author":"Mousa","year":"2021","journal-title":"Hepatology"},{"issue":"51","key":"10.1016\/j.canlet.2024.217324_bib22","doi-asserted-by":"crossref","first-page":"83951","DOI":"10.18632\/oncotarget.13796","article-title":"Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.stem.2022.08.008","article-title":"Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13866","article-title":"Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis","volume":"46","author":"Zhang","year":"2022","journal-title":"J. Food Biochem."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ijc.30219","article-title":"Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis","volume":"139","author":"Xie","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib26","article-title":"Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma","volume":"8","author":"Song","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/er.2000-0035","article-title":"Bile acid regulation of gene expression: roles of nuclear hormone receptors","volume":"23","author":"Chiang","year":"2002","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009689","article-title":"Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes","volume":"5","author":"Sheikh Abdul Kadir","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.livres.2019.01.001","article-title":"Bile acid receptors and gastrointestinal functions","volume":"3","author":"Ticho","year":"2019","journal-title":"Liver Res"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/jhep.2001.22345","article-title":"Bile acid transport and regulating functions in the human biliary epithelium","volume":"33","author":"Chignard","year":"2001","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000097800","article-title":"Decreased expression of breast cancer resistance protein in the duodenum in patients with obstructive cholestasis","volume":"74","author":"Zimmermann","year":"2006","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1665-2681(19)32070-8","article-title":"Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway","volume":"4","author":"Marin","year":"2005","journal-title":"Ann. Hepatol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib34","first-page":"638","article-title":"Tissue distribution of the human MDR3 P-glycoprotein","volume":"71","author":"Smit","year":"1994","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib35","doi-asserted-by":"crossref","DOI":"10.1208\/ps040314","article-title":"Role of MRP4 and MRP5 in biology and chemotherapy","volume":"4","author":"Sampath","year":"2002","journal-title":"AAPS PharmSci"},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib36","first-page":"1406","article-title":"Bile acid transport correlative protein mRNA expression profile in human placenta with intrahepatic cholestasis of pregnancy","volume":"30","author":"Cui","year":"2009","journal-title":"Saudi Med. J."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/mp050063u","article-title":"Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8)","volume":"3","author":"Maeda","year":"2006","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib38","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbamem.2019.03.003","article-title":"Characterization of conjugated and unconjugated bile acid transport via human organic solute transporter alpha\/beta","volume":"1861","author":"Suga","year":"2019","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"16","key":"10.1016\/j.canlet.2024.217324_bib39","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.1016\/S0021-9258(18)91006-9","article-title":"Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. Evidence for an electrogenic canalicular organic anion carrier","volume":"259","author":"Meier","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib40","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI117091","article-title":"Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+\/bile acid cotransporter","volume":"93","author":"Hagenbuch","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"7456","key":"10.1016\/j.canlet.2024.217324_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0895-4356(94)90299-2","article-title":"A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group","volume":"47","author":"McKeown-Eyssen","year":"1994","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib43","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1158\/0008-5472.CAN-16-2860","article-title":"Western diet Deregulates bile acid homeostasis, cell proliferation, and tumorigenesis in colon","volume":"77","author":"Dermadi","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12957-019-1714-5","article-title":"High expression of FABP4 and FABP6 in patients with colorectal cancer","volume":"17","author":"Zhang","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2024.217324_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3129765","article-title":"FABP6 expression correlates with immune infiltration and immunogenicity in colorectal cancer cells","volume":"2022","author":"Lian","year":"2022","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib46","first-page":"1171","article-title":"Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription","volume":"34","author":"Zuo","year":"2023","journal-title":"Anti Cancer Drugs"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib49","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/hep.27964","article-title":"Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases","volume":"62","author":"Chiang","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib50","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib51","doi-asserted-by":"crossref","first-page":"G549","DOI":"10.1152\/ajpgi.00152.2020","article-title":"Bile acid metabolism and circadian rhythms","volume":"319","author":"Yang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.livres.2019.05.001","article-title":"The acidic pathway of bile acid synthesis: not just an alternative pathway","volume":"3","author":"Pandak","year":"2019","journal-title":"Liver Research"},{"key":"10.1016\/j.canlet.2024.217324_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108311","article-title":"Bile acids and neurological disease","volume":"240","author":"Hurley","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"issue":"2\u20133","key":"10.1016\/j.canlet.2024.217324_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mam.2012.07.004","article-title":"The solute carrier family 10 (SLC10): beyond bile acid transport","volume":"34","author":"Claro da Silva","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.canlet.2024.217324_bib55","series-title":"Transporters in Drug Discovery and Development","first-page":"1","article-title":"Membrane transporters and the diseases corresponding to functional defects","author":"Lai","year":"2013"},{"key":"10.1016\/j.canlet.2024.217324_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-12-394316-3.00004-1","article-title":"The SLC10 carrier family: transport functions and molecular structure","volume":"70","author":"Doring","year":"2012","journal-title":"Curr. Top. Membr."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00210-006-0043-8","article-title":"The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships","volume":"372","author":"Geyer","year":"2006","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"Pt 18","key":"10.1016\/j.canlet.2024.217324_bib58","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/jcs.01279","article-title":"Small hepatocytes in culture develop polarized transporter expression and differentiation","volume":"117","author":"Sidler Pfandler","year":"2004","journal-title":"J. Cell Sci."},{"issue":"22","key":"10.1016\/j.canlet.2024.217324_bib59","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.3748\/wjg.v12.i22.3553","article-title":"Bile acid interactions with cholangiocytes","volume":"12","author":"Xia","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib60","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M305782200","article-title":"Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition","volume":"279","author":"Ho","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib61","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib62","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/24725552211017500","article-title":"Functional and pharmacological comparison of human and mouse Na(+)\/Taurocholate cotransporting polypeptide (NTCP)","volume":"26","author":"Floerl","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.canlet.2024.217324_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib64","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0021-9258(17)42263-0","article-title":"Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter","volume":"269","author":"Wong","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.canlet.2024.217324_bib65","doi-asserted-by":"crossref","first-page":"27228","DOI":"10.1074\/jbc.270.45.27228","article-title":"Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity","volume":"270","author":"Wong","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.canlet.2024.217324_bib66","doi-asserted-by":"crossref","first-page":"34691","DOI":"10.1074\/jbc.273.52.34691","article-title":"Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic","volume":"273","author":"Weinman","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib67","first-page":"G157","article-title":"Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter","volume":"274","author":"Craddock","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib68","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/hep.31651","article-title":"Targeting the four Pillars of enterohepatic bile salt cycling; Lessons from genetics and Pharmacology","volume":"73","author":"Kunst","year":"2021","journal-title":"Hepatology"},{"issue":"26","key":"10.1016\/j.canlet.2024.217324_bib69","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib70","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1074\/jbc.M707773200","article-title":"The 44-kDa Pim-1 kinase phosphorylates BCRP\/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells","volume":"283","author":"Xie","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.canlet.2024.217324_bib71","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050082","article-title":"Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation","volume":"7","author":"Kobuchi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.taap.2014.02.019","article-title":"The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis","volume":"277","author":"Blazquez","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"14","key":"10.1016\/j.canlet.2024.217324_bib74","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1096\/fj.02-1131fje","article-title":"The expression and functional characterization of ABCG2 in brain endothelial cells and vessels","volume":"17","author":"Zhang","year":"2003","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib76","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/hep.25591","article-title":"AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function","volume":"55","author":"Hayashi","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib77","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/jpet.105.084830","article-title":"Bile salt export pump (BSEP\/ABCB11) can transport a nonbile acid substrate, pravastatin","volume":"314","author":"Hirano","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib78","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1124\/mol.107.041459","article-title":"Involvement of multiple efflux transporters in hepatic disposition of fexofenadine","volume":"73","author":"Matsushima","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.canlet.2024.217324_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbalip.2005.10.006","article-title":"Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: a comparison of human BSEP with rat Bsep","volume":"1738","author":"Hayashi","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"201","key":"10.1016\/j.canlet.2024.217324_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-14541-4_5","article-title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation","author":"Stieger","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib81","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1432-1033.1995.406_2.x","article-title":"Molecular cloning, expression, and characterization of a human intestinal 15-kDa protein","volume":"233","author":"Fujita","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"19","key":"10.1016\/j.canlet.2024.217324_bib82","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1158\/0008-5472.CAN-06-3690","article-title":"A novel variant of ileal bile acid binding protein is up-regulated through nuclear factor-kappaB activation in colorectal adenocarcinoma","volume":"67","author":"Fang","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib83","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/prot.10289","article-title":"Insights into the bile acid transportation system: the human ileal lipid-binding protein-cholyltaurine complex and its comparison with homologous structures","volume":"50","author":"Kurz","year":"2003","journal-title":"Proteins"},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib84","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.xphs.2017.04.001","article-title":"The organic anion-transporting Peptide 2B1 is localized in the basolateral membrane of the human jejunum and Caco-2 Monolayers","volume":"106","author":"Keiser","year":"2017","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib85","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41589-022-01109-0","article-title":"Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux","volume":"18","author":"Masud","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib86","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","article-title":"MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine","volume":"87","author":"van Helvoort","year":"1996","journal-title":"Cell"},{"issue":"Pt 3","key":"10.1016\/j.canlet.2024.217324_bib87","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1042\/bj3570859","article-title":"Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor","volume":"357","author":"Raggers","year":"2001","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib88","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1194\/jlr.M032425","article-title":"Bile salt-stimulated phospholipid efflux mediated by ABCB4 localized in nonraft membranes","volume":"54","author":"Morita","year":"2013","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib89","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.07.042","article-title":"Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity","volume":"141","author":"Groen","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ejhg.2013.214","article-title":"Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction","volume":"22","author":"Degiorgio","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib91","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.21591","article-title":"Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4","volume":"46","author":"Morita","year":"2007","journal-title":"Hepatology"},{"issue":"37","key":"10.1016\/j.canlet.2024.217324_bib92","doi-asserted-by":"crossref","first-page":"12598","DOI":"10.1021\/bi050943e","article-title":"Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice","volume":"44","author":"Lam","year":"2005","journal-title":"Biochemistry"},{"issue":"41","key":"10.1016\/j.canlet.2024.217324_bib93","doi-asserted-by":"crossref","first-page":"38108","DOI":"10.1074\/jbc.M105160200","article-title":"Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity","volume":"276","author":"Ito","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib94","first-page":"929","article-title":"Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells","volume":"55","author":"Cui","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"17","key":"10.1016\/j.canlet.2024.217324_bib95","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200211220-00009","article-title":"Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs","volume":"16","author":"Huisman","year":"2002","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib96","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.510300220","article-title":"Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2","volume":"30","author":"Kamisako","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib97","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/dmd.121.000748","article-title":"Localization of xenobiotic transporters expressed at the human blood-Testis barrier","volume":"50","author":"Hau","year":"2022","journal-title":"Drug Metab. Dispos."},{"issue":"49","key":"10.1016\/j.canlet.2024.217324_bib98","doi-asserted-by":"crossref","first-page":"46400","DOI":"10.1074\/jbc.M107041200","article-title":"Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3)","volume":"276","author":"Zelcer","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib99","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1073\/pnas.96.12.6914","article-title":"MRP3, an organic anion transporter able to transport anti-cancer drugs","volume":"96","author":"Kool","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/dmd.113.055772","article-title":"The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia","volume":"42","author":"Keppler","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.canlet.2024.217324_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100325","article-title":"Effect of bile acids on the expression of MRP3 and MRP4: an in vitro study in HepG2 cell line","volume":"24","author":"Perez-Pineda","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0005-2736(00)00355-2","article-title":"Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump","volume":"1511","author":"Akita","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt 2","key":"10.1016\/j.canlet.2024.217324_bib103","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021886","article-title":"Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)","volume":"371","author":"Zelcer","year":"2003","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib104","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.V133595","article-title":"The MRP4\/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP","volume":"13","author":"van Aubel","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2003.50331","article-title":"Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane","volume":"38","author":"Rius","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib106","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1152\/ajprenal.00133.2004","article-title":"Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites","volume":"288","author":"Van Aubel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib107","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1124\/mol.106.031823","article-title":"Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney","volume":"71","author":"Ci","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib108","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0023","article-title":"Novel (sulfated) thyroid hormone transporters in the solute carrier 22 family","volume":"12","author":"Chen","year":"2023","journal-title":"Eur. Thyroid J."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib109","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","article-title":"Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney","volume":"59","author":"Cha","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"30","key":"10.1016\/j.canlet.2024.217324_bib110","doi-asserted-by":"crossref","first-page":"23161","DOI":"10.1074\/jbc.M001448200","article-title":"Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide","volume":"275","author":"Konig","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.217324_bib111","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib112","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib113","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib114","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib115","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2741\/3416","article-title":"OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids","volume":"14","author":"Ballatori","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.canlet.2024.217324_bib116","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/cells10112806","article-title":"Bile acid receptors and the gut\u2013liver Axis in nonalcoholic fatty liver disease","volume":"10","author":"Xue","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib117","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13023-022-02597-y","article-title":"Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures","volume":"17","author":"Chen","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.canlet.2024.217324_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110835","article-title":"ASBT(SLC10A2): a promising target for treatment of diseases and drug discovery","volume":"132","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217324_bib119","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fphar.2018.00931","article-title":"Ileal bile acid transporter inhibition for the treatment of chronic constipation, cholestatic pruritus, and NASH","volume":"9","author":"Al-Dury","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib120","first-page":"189","article-title":"[Advances in studies of ileal apical sodium-dependent bile acid transporter]","volume":"52","author":"Ge","year":"2017","journal-title":"Yao Xue Xue Bao"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib121","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ajg.2008.85","article-title":"Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma","volume":"104","author":"Dvorak","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib122","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.7150\/jca.18257","article-title":"Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma","volume":"8","author":"Fangning","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2024.217324_bib123","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2350-9-70","article-title":"Effects of common haplotypes of the ileal sodium dependent bile acid transporter gene on the development of sporadic and familial colorectal cancer: a case control study","volume":"9","author":"Grunhage","year":"2008","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib124","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12876-023-02679-6","article-title":"Development of an immune-related gene prognostic risk model and identification of an immune infiltration signature in the tumor microenvironment of colon cancer","volume":"23","author":"Hao","year":"2023","journal-title":"BMC Gastroenterol."},{"issue":"13","key":"10.1016\/j.canlet.2024.217324_bib125","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.7150\/ijms.45813","article-title":"A prognostic model based on the immune-related genes in colon adenocarcinoma","volume":"17","author":"Sun","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.canlet.2024.217324_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.604252","article-title":"Prognostic model of colorectal cancer Constructed by Eight immune-related genes","volume":"7","author":"Wen","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib127","first-page":"759","article-title":"Abnormality of intestinal cholesterol absorption in Apc(Min\/+) mice with colon cancer cachexia","volume":"12","author":"Yu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib128","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/carcin\/bgv107","article-title":"Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids","volume":"36","author":"Raufman","year":"2015","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib129","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41416-022-02062-4","article-title":"Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints","volume":"128","author":"Keane","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138920010792927325","article-title":"Structure and function of the human breast cancer resistance protein (BCRP\/ABCG2)","volume":"11","author":"Ni","year":"2010","journal-title":"Curr Drug Metab"},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib131","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1211\/jpp.59.9.0011","article-title":"Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats","volume":"59","author":"Yokooji","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"issue":"18","key":"10.1016\/j.canlet.2024.217324_bib132","first-page":"6635","article-title":"Acquired mutations in the MXR\/BCRP\/ABCP gene alter substrate specificity in MXR\/BCRP\/ABCP-overexpressing cells","volume":"61","author":"Honjo","year":"2001","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib133","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00204-014-1224-8","article-title":"Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics","volume":"88","author":"Jani","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib134","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.leu.2402496","article-title":"Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)","volume":"16","author":"van den Heuvel-Eibrink","year":"2002","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000520871","article-title":"Expression of BCRP\/ABCG2 protein in invasive breast cancer and response to neoadjuvant chemotherapy","volume":"45","author":"Zhang","year":"2022","journal-title":"Oncol. Res. Treat."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib136","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s11010-023-04667-6","article-title":"Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance","volume":"478","author":"Saluja","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib137","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/cpt.1710","article-title":"Protein expression and functional relevance of efflux and uptake drug transporters at the blood-brain barrier of human brain and glioblastoma","volume":"107","author":"Bao","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib138","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.18632\/oncotarget.14491","article-title":"Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients","volume":"8","author":"Hontecillas-Prieto","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib139","first-page":"1315","article-title":"Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomas","volume":"22","author":"Szczuraszek","year":"2009","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib140","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1182\/blood-2005-10-009084","article-title":"ABCG2 expression, function, and promoter methylation in human multiple myeloma","volume":"108","author":"Turner","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib141","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/ijc.31741","article-title":"Characterization of the breast cancer resistance protein (BCRP\/ABCG2) in clear cell renal cell carcinoma","volume":"143","author":"Reustle","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010255","article-title":"Expression and functional contribution of different organic cation transporters to the cellular uptake of doxorubicin into human breast cancer and cardiac tissue","volume":"23","author":"Otter","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib143","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00204-019-02394-w","article-title":"ABC transporters Mdr1a\/1b, Bcrp1, Mrp2 and Mrp3 determine the sensitivity to PhIP\/DSS-induced colon carcinogenesis and inflammation","volume":"93","author":"Durmus","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib144","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.leukres.2005.04.013","article-title":"Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma","volume":"29","author":"Raaijmakers","year":"2005","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.leukres.2004.06.004","article-title":"BCRP mRNA expression v. clinical outcome in 40 adult AML patients","volume":"29","author":"Uggla","year":"2005","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib146","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2008.10.008","article-title":"Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer","volume":"65","author":"Kim","year":"2009","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082365","article-title":"Clinical significance of ABCG2\/BCRP quantified by Fluorescent Nanoparticles in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"15","author":"Tada","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib148","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40262-020-00882-2","article-title":"Pharmacokinetic drug-drug interaction of apalutamide, Part 1: clinical studies in healthy men and patients with castration-resistant prostate cancer","volume":"59","author":"Duran","year":"2020","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib149","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1872-034X.2011.00925.x","article-title":"Paternal isodisomy of chromosome 2 in a child with bile salt export pump deficiency","volume":"42","author":"Giovannoni","year":"2012","journal-title":"Hepatol. Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1389200220666190426152830","article-title":"The role of the sodium-taurocholate Co-transporting polypeptide (NTCP) and bile salt export pump (BSEP) in related liver disease","volume":"20","author":"Lu","year":"2019","journal-title":"Curr Drug Metab"},{"issue":"29","key":"10.1016\/j.canlet.2024.217324_bib151","doi-asserted-by":"crossref","first-page":"24784","DOI":"10.1074\/jbc.M111.329318","article-title":"Abcb11 deficiency induces cholestasis coupled to impaired beta-fatty acid oxidation in mice","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib152","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1399-3046.2011.01528.x","article-title":"Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma","volume":"15","author":"Romano","year":"2011","journal-title":"Pediatr. Transplant."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib153","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2007.02.030","article-title":"Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma","volume":"150","author":"Scheimann","year":"2007","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib154","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000324688","article-title":"Genetic factors in the pathogenesis of cholangiocarcinoma","volume":"29","author":"Wadsworth","year":"2011","journal-title":"Dig. Dis."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/PAS.0000000000000585","article-title":"BSEP and MDR3: Useful immunohistochemical markers to Discriminate hepatocellular carcinomas from intrahepatic cholangiocarcinomas and hepatoid carcinomas","volume":"40","author":"Fujikura","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib156","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/his.12601","article-title":"Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma","volume":"66","author":"Lagana","year":"2015","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib157","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib158","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jhep.2014.07.003","article-title":"Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations","volume":"61","author":"Vilarinho","year":"2014","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib159","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/s41598-021-82636-z","article-title":"Bsep expression in hilar cholangiocarcinoma of rat model","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.5780","article-title":"Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice","volume":"255","author":"Wang","year":"2021","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib161","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/CS20050035","article-title":"Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis","volume":"109","author":"Monte","year":"2005","journal-title":"Clin Sci (Lond)."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib162","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1124\/dmd.117.077289","article-title":"Transporter expression in Noncancerous and cancerous liver tissue from Donors with hepatocellular carcinoma and chronic hepatitis C infection quantified by LC-MS\/MS proteomics","volume":"46","author":"Billington","year":"2018","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib163","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cpt.2633","article-title":"Quantitative proteomics of hepatic drug-metabolizing enzymes and transporters in patients with colorectal cancer metastasis","volume":"112","author":"Vasilogianni","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib164","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0167-4838(91)90152-P","article-title":"Characterization of a novel 14 kDa bile acid-binding protein from rat ileal cytosol","volume":"1078","author":"Lin","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib165","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1073\/pnas.91.11.4741","article-title":"Molecular cloning, tissue distribution, and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol","volume":"91","author":"Gong","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2\u20133","key":"10.1016\/j.canlet.2024.217324_bib166","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbaexp.2003.09.008","article-title":"Human ileal bile acid-binding protein promoter and the effects of CDX2","volume":"1630","author":"Barley","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"17","key":"10.1016\/j.canlet.2024.217324_bib167","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1158\/1078-0432.CCR-05-2045","article-title":"Fatty acid binding protein 6 is overexpressed in colorectal cancer","volume":"12","author":"Ohmachi","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101460","article-title":"Expression profiles and prognostic value of FABPs in colorectal adenocarcinomas","volume":"9","author":"Prayugo","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib169","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bjs.1800730327","article-title":"Experimental colorectal cancer: the relationship of diet and faecal bile acid concentration to tumour induction","volume":"73","author":"Galloway","year":"1986","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12860-020-00295-w","article-title":"Molecular docking and machine learning analysis of Abemaciclib in colon cancer","volume":"21","author":"Linares-Blanco","year":"2020","journal-title":"BMC Mol Cell Biol"},{"key":"10.1016\/j.canlet.2024.217324_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.666199","article-title":"Prognostic implication of a novel metabolism-related gene signature in hepatocellular carcinoma","volume":"11","author":"Yuan","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102782","article-title":"Inhibition of FABP6 reduces tumor cell invasion and angiogenesis through the decrease in MMP-2 and VEGF in human glioblastoma cells","volume":"10","author":"Pai","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2024.217324_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106732","article-title":"Comprehensive analysis of the roles of fatty acid transport related proteins in clear cell renal cell carcinoma","volume":"167","author":"Zheng","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib174","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13040-021-00261-y","article-title":"A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma","volume":"14","author":"Yan","year":"2021","journal-title":"BioData Min."},{"issue":"50","key":"10.1016\/j.canlet.2024.217324_bib175","doi-asserted-by":"crossref","first-page":"82783","DOI":"10.18632\/oncotarget.12635","article-title":"The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance","volume":"7","author":"Al Fayi","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042154","article-title":"Fatty acid binding protein 6 inhibition decreases cell cycle progression, migration and Autophagy in bladder cancers","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6031","key":"10.1016\/j.canlet.2024.217324_bib177","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/316820a0","article-title":"Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies","volume":"316","author":"Kartner","year":"1985","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.canlet.2024.217324_bib178","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the Universal protein Knowledgebase in 2023","volume":"51","author":"UniProt","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib179","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.83.12.4538","article-title":"Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells","volume":"83","author":"Roninson","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib180","first-page":"321","article-title":"Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation","volume":"14","author":"Foroutan","year":"2011","journal-title":"Arch. Iran. Med."},{"issue":"7\u20138","key":"10.1016\/j.canlet.2024.217324_bib181","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib182","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2125.2008.03180.x","article-title":"ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients","volume":"66","author":"Zhang","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib183","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pharep.2017.10.005","article-title":"P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats","volume":"70","author":"Zhang","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib184","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/gtmb.2013.0293","article-title":"Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients","volume":"18","author":"Uludag","year":"2014","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib185","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib186","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031166","article-title":"Spheroid culture differentially Affects cancer cell sensitivity to drugs in melanoma and RCC models","volume":"23","author":"Filipiak-Duliban","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib187","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2559.2008.03026.x","article-title":"Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas","volume":"52","author":"Kamata","year":"2008","journal-title":"Histopathology."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib188","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4161\/cbt.26603","article-title":"mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2","volume":"15","author":"Rahgozar","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib189","first-page":"462","article-title":"[The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma]","volume":"32","author":"Zhu","year":"1997","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11095-020-02896-8","article-title":"Drug elimination alteration in acute lymphoblastic leukemia mediated by renal transporters and Glomerular filtration","volume":"37","author":"Zhou","year":"2020","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib191","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/s41375-022-01587-0","article-title":"Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution","volume":"36","author":"Richter-Pechanska","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib192","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/S1516-31802004000400007","article-title":"Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia","volume":"122","author":"Valera","year":"2004","journal-title":"Sao Paulo Med. J."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib193","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5732\/cjc.009.10599","article-title":"Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma","volume":"29","author":"Gan","year":"2010","journal-title":"Chin. J. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib194","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1478-3231.2005.01033.x","article-title":"Hepatobiliary transporter expression in human hepatocellular carcinoma","volume":"25","author":"Zollner","year":"2005","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib195","article-title":"Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma","volume":"9","author":"Warta","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib196","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.31557\/APJCP.2020.21.7.1899","article-title":"Association of multidrug resistance gene-1 (MDR1 C1236T) polymorphism with the risk of acute myeloid leukemia in a Moroccan population","volume":"21","author":"Ait Boujmia","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.canlet.2024.217324_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2022.106854","article-title":"Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients","volume":"117","author":"Hegazi","year":"2022","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib198","first-page":"720","article-title":"MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia","volume":"58","author":"Jamroziak","year":"2006","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib199","first-page":"211","article-title":"A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women","volume":"18","author":"Zubor","year":"2007","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101181","article-title":"Tepoxalin increases chemotherapy efficacy in drug-resistant breast cancer cells overexpressing the multidrug transporter gene ABCB1","volume":"14","author":"McQuerry","year":"2021","journal-title":"Transl Oncol"},{"issue":"50","key":"10.1016\/j.canlet.2024.217324_bib201","doi-asserted-by":"crossref","first-page":"83502","DOI":"10.18632\/oncotarget.13148","article-title":"Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib202","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00280-021-04310-5","article-title":"Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression","volume":"88","author":"Sugiu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib203","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1535-7163.833.3.7","article-title":"Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells","volume":"3","author":"Duan","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.canlet.2024.217324_bib204","article-title":"Hedgehog-Gli2 signaling promotes chemoresistance in ovarian cancer cells by regulating MDR1","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib205","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1002\/j.1460-2075.1987.tb02653.x","article-title":"The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver","volume":"6","author":"Van der Bliek","year":"1987","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib206","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1440-1746.1999.01886.x","article-title":"Molecular aspects of organic compound transport across the plasma membrane of hepatocytes","volume":"14","author":"Kamisako","year":"1999","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2024.217324_bib207","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/954781","article-title":"Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts","volume":"2014","author":"Morita","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib208","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jss.2014.07.055","article-title":"Expression of indocyanine green-related transporters in hepatocellular carcinoma","volume":"193","author":"Shibasaki","year":"2015","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib209","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12889","article-title":"Hepatocarcinogenesis in multidrug-resistant P-glycoprotein 3 deficiency","volume":"21","author":"Vij","year":"2017","journal-title":"Pediatr. Transplant."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib210","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2012.01.025","article-title":"ABCB4\/MDR3 gene mutations and cholangiocarcinomas","volume":"57","author":"Tougeron","year":"2012","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023943","article-title":"Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer","volume":"6","author":"Philips","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib212","first-page":"173","article-title":"Markers of chemoradiation resistance in patients with locally advanced head and neck squamous cell carcinoma, treated by intra-arterial carboplatin and concurrent radiation","volume":"27","author":"Mannarini","year":"2007","journal-title":"Acta Otorhinolaryngol. Ital."},{"issue":"117","key":"10.1016\/j.canlet.2024.217324_bib213","first-page":"1556","article-title":"Expression of multi-drug resistance-related genes MDR3 and MRP as prognostic factors in clinical liver cancer patients","volume":"59","author":"Yu","year":"2012","journal-title":"Hepato-gastroenterol"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib214","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ijc.1498","article-title":"Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma","volume":"94","author":"Nies","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib215","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s12253-018-0386-8","article-title":"Immunohistochemical Assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma","volume":"25","author":"Cirqueira","year":"2019","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib216","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/s41598-019-38667-8","article-title":"Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer","volume":"9","author":"Myint","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib217","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jcpt.12197","article-title":"Clinical impact of ABCC1 and ABCC2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients","volume":"39","author":"Au","year":"2014","journal-title":"J Clin Pharm Ther."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib218","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00280-009-1046-1","article-title":"MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer","volume":"65","author":"Sun","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib219","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12253-011-9449-9","article-title":"ABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome","volume":"18","author":"Maciejczyk","year":"2012","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/0284186X.2018.1537508","article-title":"Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study","volume":"58","author":"Hjorth","year":"2019","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib221","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/cncr.25510","article-title":"Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome","volume":"117","author":"Tanaka","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib222","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/humu.22041","article-title":"Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells","volume":"33","author":"Arlanov","year":"2012","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib223","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjc.6606071","article-title":"Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma","volume":"104","author":"Yamasaki","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217324_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172883","article-title":"Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells","volume":"868","author":"Valinezhad Sani","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib225","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/cas.13097","article-title":"Wnt-beta-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer","volume":"107","author":"Kobayashi","year":"2016","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib226","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1111\/liv.14587","article-title":"Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: implications for combination trials","volume":"40","author":"Diaz-Gonzalez","year":"2020","journal-title":"Liver Int."},{"issue":"16","key":"10.1016\/j.canlet.2024.217324_bib227","first-page":"3537","article-title":"Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines","volume":"57","author":"Kool","year":"1997","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.canlet.2024.217324_bib228","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/jnci\/90.22.1735","article-title":"Characterization of MOAT-C and MOAT-D, new members of the MRP\/cMOAT subfamily of transporter proteins","volume":"90","author":"Belinsky","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib229","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/bbrc.1998.9546","article-title":"Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2\/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport","volume":"252","author":"Uchiumi","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2133\/dmpk.22.129","article-title":"Genetic variations of the ABC transporter gene ABCC3 in a Japanese population","volume":"22","author":"Fukushima-Uesaka","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"issue":"19","key":"10.1016\/j.canlet.2024.217324_bib231","first-page":"7225","article-title":"Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport","volume":"61","author":"Zeng","year":"2001","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.canlet.2024.217324_bib232","first-page":"4779","article-title":"Transport of amphipathic anions by human multidrug resistance protein 3","volume":"60","author":"Zeng","year":"2000","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib233","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/gcc.21967","article-title":"Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer","volume":"51","author":"Partanen","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.canlet.2024.217324_bib234","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/med-2020-0016","article-title":"Bioinformatics analysis of the expression of ATP binding cassette subfamily C member 3 (ABCC3) in human glioma","volume":"15","author":"Sun","year":"2020","journal-title":"Open Med."},{"issue":"16","key":"10.1016\/j.canlet.2024.217324_bib235","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnci\/djr256","article-title":"ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux","volume":"103","author":"Henderson","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib236","first-page":"545","article-title":"[Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients]","volume":"78","author":"Sedlakova","year":"2013","journal-title":"Ceska Gynekol."},{"key":"10.1016\/j.canlet.2024.217324_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2019.04.004","article-title":"ABCC3 is a novel target for the treatment of pancreatic cancer","volume":"73","author":"Adamska","year":"2019","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.canlet.2024.217324_bib238","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2017.06.024","article-title":"Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo","volume":"83","author":"Murray","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"13","key":"10.1016\/j.canlet.2024.217324_bib239","first-page":"2741","article-title":"Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein\/canalicular multispecific organic anion transporter-related transporter","volume":"58","author":"Lee","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217324_bib240","series-title":"Comprehensive Toxicology","first-page":"557","article-title":"4.26 - efflux transporters","author":"Jungsuwadee","year":"2010"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib241","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1007\/s11033-014-3423-z","article-title":"ABC transporters as differentiation markers in glioblastoma cells","volume":"41","author":"Rama","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canlet.2024.217324_bib242","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ijbiomac.2020.06.106","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation","volume":"161","author":"Colavita","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib243","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71181-w","article-title":"Multidrug transporter MRP4\/ABCC4 as a key determinant of pancreatic cancer aggressiveness","volume":"10","author":"Sahores","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.217324_bib244","first-page":"343","article-title":"ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer","volume":"7","author":"Zhao","year":"2014","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0973-1482.143334","article-title":"The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells","volume":"11","author":"He","year":"2015","journal-title":"J Cancer Res Ther"},{"issue":"13","key":"10.1016\/j.canlet.2024.217324_bib246","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/pros.20809","article-title":"Androgen regulation of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in prostate cancer","volume":"68","author":"Ho","year":"2008","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib247","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00428-013-1390-8","article-title":"Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression","volume":"462","author":"Montani","year":"2013","journal-title":"Virchows Arch."},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib248","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2008-11-191098","article-title":"Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia","volume":"114","author":"Ansari","year":"2009","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.canlet.2024.217324_bib249","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207664","article-title":"Roles of ABCC1 and ABCC4 in proliferation and migration of breast cancer cell lines","volume":"21","author":"Low","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib250","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/ijc.33005","article-title":"ABCC4\/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer","volume":"147","author":"Jung","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"19","key":"10.1016\/j.canlet.2024.217324_bib251","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.18632\/oncotarget.2425","article-title":"Multidrug resistance protein 4\/ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia","volume":"5","author":"Copsel","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib252","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092000","article-title":"Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development","volume":"9","author":"Pereira","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217324_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105773","article-title":"Metabolomics study of the metabolic changes in hepatoblastoma cells in response to NTCP\/SLC10A1 overexpression","volume":"125","author":"Wang","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7916","key":"10.1016\/j.canlet.2024.217324_bib254","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41586-022-04723-z","article-title":"Structural basis of sodium-dependent bile salt uptake into the liver","volume":"606","author":"Goutam","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib255","article-title":"Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP","volume":"1866","author":"Appelman","year":"2021","journal-title":"Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids"},{"issue":"23","key":"10.1016\/j.canlet.2024.217324_bib256","doi-asserted-by":"crossref","first-page":"10629","DOI":"10.1073\/pnas.88.23.10629","article-title":"Functional expression cloning and characterization of the hepatocyte Na+\/bile acid cotransport system","volume":"88","author":"Hagenbuch","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib257","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.canlet.2024.217324_bib258","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mce.2009.08.003","article-title":"Study of the transport of thyroid hormone by transporters of the SLC10 family","volume":"315","author":"Visser","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.canlet.2024.217324_bib259","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221109646","article-title":"NTCP change in rats of hilar cholangiocarcinoma and therapeutic significance","volume":"21","author":"Zhang","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib260","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3892\/mmr.2013.1516","article-title":"cDNA microarray pro fi ling of rat cholangiocarcinoma induced by thioacetamide","volume":"8","author":"Yeh","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06463","article-title":"Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinoma","volume":"7","author":"Tran","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.canlet.2024.217324_bib262","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2147\/JHC.S392586","article-title":"The clinical relevance and immune correlation of SLC10 family genes in liver cancer","volume":"9","author":"Tian","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"19","key":"10.1016\/j.canlet.2024.217324_bib263","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1074\/jbc.274.19.13675","article-title":"Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain","volume":"274","author":"Kusuhara","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2\u20133","key":"10.1016\/j.canlet.2024.217324_bib264","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(01)00962-1","article-title":"Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters","volume":"419","author":"Takeda","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41065-022-00243-y","article-title":"Susceptibility genes of hyperuricemia and gout","volume":"159","author":"Nian","year":"2022","journal-title":"Hereditas"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib266","doi-asserted-by":"crossref","first-page":"F1332","DOI":"10.1152\/ajprenal.00319.2007","article-title":"Organic anion transporter 3 (Oat3\/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G","volume":"293","author":"Vanwert","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib267","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/med.20014","article-title":"Towards an understanding of organic anion transporters: structure-function relationships","volume":"24","author":"You","year":"2004","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib268","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.peptides.2012.01.007","article-title":"Organic anion transporters involved in the excretion of bestatin in the kidney","volume":"33","author":"Zhu","year":"2012","journal-title":"Peptides"},{"issue":"19","key":"10.1016\/j.canlet.2024.217324_bib269","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194772","article-title":"Organic anion transporters (OAT) and other SLC22 transporters in progression of renal cell carcinoma","volume":"14","author":"Whisenant","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib270","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1074\/jbc.M411092200","article-title":"Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib271","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2217\/14622416.10.3.339","article-title":"Pharmacogenetics of the organic anion transporting polypeptide 1A2","volume":"10","author":"Franke","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib272","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cbpc.2003.12.004","article-title":"Molecular cloning and functional characterization of the bovine (Bos taurus) organic anion transporting polypeptide Oatp1a2 (Slco1a2)","volume":"137","author":"Geyer","year":"2004","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib273","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.exer.2004.08.013","article-title":"Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium","volume":"80","author":"Gao","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib274","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13020-020-00351-9","article-title":"The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb\/food interactions","volume":"15","author":"Ali","year":"2020","journal-title":"Chin. Med."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib275","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1208\/s12248-013-9515-1","article-title":"Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2","volume":"15","author":"Zhou","year":"2013","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib276","first-page":"22","article-title":"Molecular regulation of organic anion transporting polypeptide 1A2 (OATP1A2)by taurocholic acid in Bewo Cells","volume":"60","author":"Yang","year":"2014","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"22","key":"10.1016\/j.canlet.2024.217324_bib277","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1158\/0008-5472.CAN-08-0265","article-title":"Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer","volume":"68","author":"Meyer zu Schwabedissen","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib278","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.112.192344","article-title":"Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells","volume":"342","author":"Banerjee","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib279","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4161\/cbt.11.9.15176","article-title":"The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer","volume":"11","author":"Wlcek","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib280","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bcp.2006.06.007","article-title":"Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps","volume":"72","author":"Ballestero","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib281","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bcp.2012.07.026","article-title":"Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions","volume":"84","author":"Arakawa","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib282","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2133\/dmpk.DMPK-10-RV-094","article-title":"Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions","volume":"26","author":"Shitara","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib283","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4161\/cbt.4.8.1867","article-title":"Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel","volume":"4","author":"Smith","year":"2005","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib284","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/dmd.104.003244","article-title":"Hepatic uptake of the novel antifungal agent caspofungin","volume":"33","author":"Sandhu","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib285","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/dmd.105.004622","article-title":"Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans","volume":"33","author":"Shimizu","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib286","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/jpet.105.085589","volume":"314","author":"Matsushima","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib287","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/dmdi-2013-0062","article-title":"Role of OATP-1B1 and\/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors","volume":"29","author":"Khurana","year":"2014","journal-title":"Drug Metabol. Drug Interact."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib288","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-022-06596-2","article-title":"Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark","volume":"194","author":"Hjorth","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib289","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/pcan.2016.42","article-title":"Role of OATP transporters in steroid uptake by prostate cancer cells in vivo","volume":"20","author":"Green","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canlet.2024.217324_bib290","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9711179","article-title":"OATP1B1 plays an important role in the transport and treatment efficacy of sorafenib in hepatocellular carcinoma","volume":"2021","author":"Wen","year":"2021","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib291","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/cts.12879","article-title":"Effect of SLCO1B1 polymorphisms on high-dose methotrexate clearance in children and young adults with leukemia and lymphoblastic lymphoma","volume":"14","author":"Schulte","year":"2021","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib292","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/jpet.104.068056","article-title":"Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans","volume":"311","author":"Hirano","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib293","doi-asserted-by":"crossref","first-page":"G271","DOI":"10.1152\/ajpgi.00075.2007","article-title":"Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport","volume":"293","author":"Mahagita","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"D1","key":"10.1016\/j.canlet.2024.217324_bib294","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1124\/dmd.119.089847","article-title":"OATP1B3 expression and function is modulated by Coexpression with OCT1, OATP1B1, and NTCP","volume":"48","author":"Zhang","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib296","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1158\/1078-0432.CCR-07-4118","article-title":"Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer","volume":"14","author":"Hamada","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib297","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020372","article-title":"Expression of OATP family members in hormone-related cancers: potential markers of progression","volume":"6","author":"Pressler","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib298","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsbmb.2010.06.014","article-title":"Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer","volume":"122","author":"Maeda","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib299","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/molpharm.122.000539","article-title":"Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitors","volume":"102","author":"Haberkorn","year":"2022","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib300","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/s41598-021-84960-w","article-title":"Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers","volume":"11","author":"Lochrin","year":"2021","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.canlet.2024.217324_bib301","doi-asserted-by":"crossref","first-page":"27473","DOI":"10.1074\/jbc.M301106200","article-title":"Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta","volume":"278","author":"Seward","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib302","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1074\/jbc.M412752200","article-title":"The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter","volume":"280","author":"Dawson","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.canlet.2024.217324_bib303","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1073\/pnas.161099898","article-title":"Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate","volume":"98","author":"Wang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib304","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1087057116657513","article-title":"Virtual screening of DrugBank reveals two drugs as new BCRP inhibitors","volume":"22","author":"Montanari","year":"2017","journal-title":"SLAS Discov"},{"key":"10.1016\/j.canlet.2024.217324_bib305","first-page":"1155","article-title":"Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP\/ABCG2) inhibitors","volume":"22","author":"Dutra","year":"2023","journal-title":"EXCLI J"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib306","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061366","article-title":"Erdafitinib Resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs","volume":"12","author":"Wu","year":"2020","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.canlet.2024.217324_bib307","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813972","article-title":"Furmonertinib, a third-generation EGFR tyrosine kinase inhibitor, Overcomes multidrug resistance through inhibiting ABCB1 and ABCG2 in cancer cells","volume":"24","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217324_bib308","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116038","article-title":"Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with beta-caryophyllene oxide","volume":"170","author":"Ortiz-Rivero","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"24","key":"10.1016\/j.canlet.2024.217324_bib309","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1021\/acs.jcim.1c01460","article-title":"Identifying novel inhibitors for hepatic organic anion transporting polypeptides by machine learning-based virtual screening","volume":"62","author":"Tuerkova","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.canlet.2024.217324_bib310","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxlet.2022.06.004","article-title":"Hepatic bile acid synthesis and secretion: comparison of in vitro methods","volume":"365","author":"de Bruijn","year":"2022","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib311","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/acs.molpharmaceut.5b00594","article-title":"Flagging drugs that inhibit the bile salt export pump","volume":"13","author":"Montanari","year":"2016","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib312","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1021\/mp4001348","article-title":"Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia","volume":"10","author":"Chang","year":"2013","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib313","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11095-011-0564-9","article-title":"In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions","volume":"29","author":"Karlgren","year":"2012","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib314","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejps.2008.06.017","article-title":"Emtricitabine: inhibitor and substrate of multidrug resistance associated protein","volume":"35","author":"Bousquet","year":"2008","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib315","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bcp.2014.11.006","article-title":"Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen","volume":"93","author":"Cheung","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib316","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcmgh.2017.11.011","article-title":"Intestinal farnesoid X receptor activation by pharmacologic inhibition of the organic solute transporter alpha-beta","volume":"5","author":"van de Wiel","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.canlet.2024.217324_bib317","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113682","article-title":"Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters","volume":"171","author":"Al-Abdulla","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217324_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116077","article-title":"Ergosterol peroxide blocks HDV infection as a novel entry inhibitor by targeting human NTCP receptor","volume":"170","author":"Chiou","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib319","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/AAC.01532-12","article-title":"Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy","volume":"57","author":"Perwitasari","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib320","doi-asserted-by":"crossref","DOI":"10.3390\/v15122366","article-title":"Antiviral activity of probenecid and Oseltamivir on influenza virus Replication","volume":"15","author":"Murray","year":"2023","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/j.canlet.2024.217324_bib321","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1182\/bloodadvances.2020001576","article-title":"Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models","volume":"4","author":"Morrish","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.canlet.2024.217324_bib322","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105833","article-title":"Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation","volume":"75","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.canlet.2024.217324_bib323","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153629","article-title":"Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR","volume":"90","author":"Kong","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2024.217324_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153153","article-title":"Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor","volume":"68","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166822","article-title":"The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: based on targeted metabolomics and molecular biology technology","volume":"1869","author":"Fu","year":"2023","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib326","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-234185","article-title":"Odevixibat and partial external biliary diversion showed equal improvement of cholestasis in a patient with progressive familial intrahepatic cholestasis","volume":"13","author":"Slavetinsky","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"15","key":"10.1016\/j.canlet.2024.217324_bib327","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s40265-021-01594-y","article-title":"Odevixibat: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"issue":"15","key":"10.1016\/j.canlet.2024.217324_bib328","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s40265-021-01608-9","article-title":"Correction to: odevixibat: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.canlet.2024.217324_bib329","doi-asserted-by":"crossref","DOI":"10.3390\/children9050669","article-title":"Ileal bile acid transporter inhibition reduces post-transplant diarrhea and growth failure in FIC1 disease-A case Report","volume":"9","author":"Ohlendorf","year":"2022","journal-title":"Children"},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib330","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib331","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1097\/PG9.0000000000000301","article-title":"Odevixibat Treatment of Alagille Syndrome: A Case Report","volume":"4","author":"Ganschow","year":"2023","journal-title":"JPGN reports"},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib332","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/13543784.2022.2151890","article-title":"Odevixibat: an investigational inhibitor of the ileal bile acid transporter (IBAT) for the treatment of biliary atresia","volume":"31","author":"Laue","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib333","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.2011.04675.x","article-title":"Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study","volume":"34","author":"Simren","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib334","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/bcp.13698","article-title":"Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: a randomized controlled trial","volume":"84","author":"Kumagai","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib335","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/17474124.2018.1522248","article-title":"Elobixibat for the treatment of constipation","volume":"12","author":"Chedid","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10074","key":"10.1016\/j.canlet.2024.217324_bib336","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib337","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12876-016-0481-9","article-title":"BAT117213: ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial","volume":"16","author":"Hegade","year":"2016","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib338","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12876-017-0736-0","article-title":"Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial","volume":"18","author":"Tiessen","year":"2018","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib339","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40360-018-0200-y","article-title":"A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis","volume":"19","author":"Palmer","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib340","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep4.1305","article-title":"A randomized, controlled, phase 2 study of maralixibat in the treatment of itching associated with primary biliary cholangitis","volume":"3","author":"Mayo","year":"2019","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib341","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/hep4.1992","article-title":"Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome","volume":"6","author":"Shneider","year":"2022","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib342","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2014.03.025","article-title":"Prednisolone increases enterohepatic cycling of bile acids by induction of Asbt and promotes reverse cholesterol transport","volume":"61","author":"Out","year":"2014","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib343","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HEP.0000000000000376","article-title":"A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans","volume":"78","author":"Caballero-Camino","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib344","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcmgh.2021.04.013","article-title":"Combined ASBT inhibitor and FGF15 treatment improves therapeutic efficacy in experimental nonalcoholic steatohepatitis","volume":"12","author":"Matye","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib345","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41401-018-0195-3","article-title":"A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters","volume":"40","author":"Ge","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib346","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cgh.2013.04.029","article-title":"Methods for diagnosis of bile acid malabsorption in clinical practice","volume":"11","author":"Vijayvargiya","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib347","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1021\/mp800117b","article-title":"Generation of a novel antibody probe to the apical sodium-dependent bile acid transporter that inhibits ileal bile acid absorption","volume":"6","author":"Montagnani","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.canlet.2024.217324_bib348","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2015.08.022","article-title":"Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)","volume":"216","author":"Lozano","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.canlet.2024.217324_bib349","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Davit-Spraul","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib350","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/petr.12751","article-title":"High affinity anti-BSEP antibodies after liver transplantation for PFIC-2 - successful treatment with immunoadsorption and B-cell depletion","volume":"20","author":"Kubitz","year":"2016","journal-title":"Pediatr. Transplant."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib351","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/mp400471e","article-title":"An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown","volume":"11","author":"Yang","year":"2014","journal-title":"Mol. Pharm."},{"issue":"23","key":"10.1016\/j.canlet.2024.217324_bib352","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233810","article-title":"A high hepatic uptake of conjugated bile acids promotes colorectal cancer-associated liver metastasis","volume":"11","author":"Zheng","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib353","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/cas.16132","article-title":"Downregulation of ABCC3 activates MAPK signaling through accumulation of deoxycholic acid in colorectal cancer cells","volume":"115","author":"Sato","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2024.217324_bib354","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107539","article-title":"Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges","volume":"212","author":"Li","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2024.217324_bib355","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108184","article-title":"Corrigendum to \"Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges\" [Pharmacology & Therapeutics 212 (2020) 107539]","volume":"234","author":"Li","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2024.217324_bib356","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1152\/ajplegacy.1959.197.6.1339","article-title":"Inhibition of cholesterol biosynthesis by cholic acid","volume":"197","author":"Beher","year":"1959","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib357","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.20238","article-title":"Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis","volume":"39","author":"Smith","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2024.217324_bib358","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108869","article-title":"Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet","volume":"100","author":"Chun","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.canlet.2024.217324_bib359","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.897867","article-title":"Distinct bile acid signature in Parkinson's disease with Mild Cognitive Impairment","volume":"13","author":"Nie","year":"2022","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib360","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000503","article-title":"Association of serum and fecal bile acid patterns with liver fibrosis in Biopsy-Proven nonalcoholic fatty liver disease: an observational study","volume":"13","author":"Kasai","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib361","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1515\/cclm-2021-1176","article-title":"Determination of individual bile acids in acute respiratory distress syndrome reveals a specific pattern of primary and secondary bile acids and a shift to the acidic pathway as an adaptive response to the critical condition","volume":"60","author":"Harnisch","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib362","article-title":"Differences in gut microbiota and fecal bile acids between Caucasian and Hispanic children and young adults with ulcerative colitis","volume":"11","author":"Aboud Syriani","year":"2023","journal-title":"Physiol Rep"},{"issue":"11","key":"10.1016\/j.canlet.2024.217324_bib363","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13111160","article-title":"Identification of novel biomarkers for early diagnosis of Atherosclerosis using high-Resolution metabolomics","volume":"13","author":"Sardar","year":"2023","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib364","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/cei\/uxae006","article-title":"The alteration of mucosal bile acid profile is associated with nerve growth factor expression in mast cells and bowel symptoms in diarrhea-predominant irritable bowel syndrome","volume":"216","author":"Wu","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib365","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3892\/ol.2017.6763","article-title":"Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma","volume":"14","author":"Proungvitaya","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib366","first-page":"48","article-title":"[Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis]","volume":"91","author":"Vakhrushev","year":"2019","journal-title":"Ter. Arkh."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib367","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep4.1490","article-title":"Bile acid changes associated with liver fibrosis and Steatosis in the Mexican-American population of South Texas","volume":"4","author":"Kwan","year":"2020","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib368","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/gutjnl-2021-325189","article-title":"Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2024.217324_bib369","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110508","article-title":"Glycocholic acid aggravates liver fibrosis by promoting the up-regulation of connective tissue growth factor in hepatocytes","volume":"101","author":"Yuan","year":"2023","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib370","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/s41598-024-52969-6","article-title":"Bile acid profiles in adult patients with biliary atresia who achieve native liver survival after portoenterostomy","volume":"14","author":"Takeda","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.canlet.2024.217324_bib371","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)38051-2","article-title":"Studies on fat digestion, absorption, and transport in the suckling rat. III. Composition of bile and evidence for enterohepatic circulation of bile salts","volume":"23","author":"Staggers","year":"1982","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib372","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12876-018-0842-7","article-title":"Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.canlet.2024.217324_bib373","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1242364","article-title":"Biliary microbiota and bile acid composition in cholelithiasis","volume":"2020","author":"Petrov","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.canlet.2024.217324_bib374","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211017725","article-title":"The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection","volume":"14","author":"Mullish","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib375","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/apt.17533","article-title":"Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis","volume":"58","author":"Wiese","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib376","first-page":"523","article-title":"Genetic and clinical features of patients with intrahepatic cholestasis caused by citrin deficiency","volume":"36","author":"Sun","year":"2023","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib377","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12872-024-03736-y","article-title":"Serum metabolism characteristics of patients with myocardial injury after noncardiac surgery explored by the untargeted metabolomics approach","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib378","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197201062860101","article-title":"Dissolution of cholesterol gallstones by chenodeoxycholic acid","volume":"286","author":"Danzinger","year":"1972","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib379","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.canlet.2024.217324_bib380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632864","article-title":"Bile acids elevated in chronic Periaortitis could activate farnesoid-X-receptor to suppress IL-6 production by Macrophages","volume":"12","author":"Cao","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib381","first-page":"159","article-title":"Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro","volume":"19","author":"Raedsch","year":"1981","journal-title":"Z. Gastroenterol."},{"issue":"Pt 1","key":"10.1016\/j.canlet.2024.217324_bib382","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.freeradbiomed.2022.10.270","article-title":"The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin-linked MAFLD","volume":"193","author":"Liu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib383","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002287","article-title":"Genetic variants associated with beta-cell function and insulin sensitivity potentially influence bile acid metabolites and gestational diabetes mellitus in a Chinese population","volume":"9","author":"Zhou","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib384","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/liv.15481","article-title":"Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension","volume":"43","author":"\u017d\u00ed\u017ealov\u00e1","year":"2023","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib385","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.dld.2021.06.034","article-title":"Serum bile acids in cystic fibrosis patients - glycodeoxycholic acid as a potential marker of liver disease","volume":"54","author":"Drzyma\u0142a-Czy\u017c","year":"2022","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib386","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/jcsm.13342","article-title":"Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis","volume":"14","author":"Aliwa","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib387","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12944-023-01971-4","article-title":"Altered fecal bile acid composition in active ulcerative colitis","volume":"22","author":"Sommersberger","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib388","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1080\/00365521.2023.2200518","article-title":"Bile acid alterations associated with indolent course of inflammatory bowel disease","volume":"58","author":"Liu","year":"2023","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib389","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2337\/dc21-1023","article-title":"Impaired insulin clearance as the initial regulator of Obesity-associated Hyperinsulinemia: novel insight into the underlying mechanism based on serum bile acid profiles","volume":"45","author":"Fu","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11306-020-01762-3","article-title":"Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore Longitudinal Study of Aging","volume":"17","author":"Yamaguchi","year":"2021","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib391","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/s41467-022-30712-x","article-title":"The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib392","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12876-023-02759-7","article-title":"Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data","volume":"23","author":"Hu","year":"2023","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib393","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/S2542-5196(23)00257-7","article-title":"In utero exposures to perfluoroalkyl substances and the human fetal liver metabolome in Scotland: a cross-sectional study","volume":"8","author":"Hy\u00f6tyl\u00e4inen","year":"2024","journal-title":"Lancet Planet. Health"},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib394","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.canlet.2024.217324_bib395","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132930","article-title":"Associations between ileal Juice bile acids and colorectal advanced adenoma","volume":"15","author":"Luu","year":"2023","journal-title":"Nutrients"},{"issue":"14","key":"10.1016\/j.canlet.2024.217324_bib396","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1042\/CS20210198","article-title":"Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress","volume":"135","author":"Cheng","year":"2021","journal-title":"Clin Sci (Lond)."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib397","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20351-z","article-title":"Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients","volume":"12","author":"St\u00fcrznickel","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.217324_bib398","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3181\/00379727-103-25529","article-title":"Effect of cholic and hyodeoxycholic acids on metabolism of exogenous cholesterol in mice","volume":"103","author":"Beher","year":"1960","journal-title":"Proc Soc Exp Biol Med"},{"issue":"12","key":"10.1016\/j.canlet.2024.217324_bib399","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jhbp.678","article-title":"Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model","volume":"26","author":"Kodama","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"D1","key":"10.1016\/j.canlet.2024.217324_bib400","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.canlet.2024.217324_bib401","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib402","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"36","key":"10.1016\/j.canlet.2024.217324_bib403","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.canlet.2024.217324_bib404","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00424-014-1596-x","article-title":"Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS","volume":"467","author":"Gao","year":"2015","journal-title":"Pflugers Arch"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib405","doi-asserted-by":"crossref","first-page":"C570","DOI":"10.1152\/ajpcell.00436.2008","article-title":"Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters","volume":"296","author":"Leuthold","year":"2009","journal-title":"Am J Physiol Cell Physiol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib406","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0016-5085(95)90588-X","article-title":"Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver","volume":"109","author":"Kullak-Ublick","year":"1995","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.canlet.2024.217324_bib407","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/bph.13060","article-title":"Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells","volume":"172","author":"Chan","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib408","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.116.105544","article-title":"Contribution of organic anion-transporting polypeptides 1A\/1B to doxorubicin uptake and clearance","volume":"91","author":"Lee","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217324_bib409","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11095-005-2503-0","article-title":"Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney","volume":"22","author":"Tahara","year":"2005","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"37","key":"10.1016\/j.canlet.2024.217324_bib410","article-title":"SLC22A8: an indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics","volume":"101","author":"Xu","year":"2022","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib411","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/acs.molpharmaceut.7b00852","article-title":"Drug clearance from Cerebrospinal Fluid mediated by organic anion transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid membrane of rats","volume":"15","author":"Zhang","year":"2018","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.canlet.2024.217324_bib412","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0092-8674(86)90594-5","article-title":"Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins","volume":"47","author":"Gros","year":"1986","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.canlet.2024.217324_bib413","doi-asserted-by":"crossref","first-page":"43058","DOI":"10.1074\/jbc.M207735200","article-title":"A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter","volume":"277","author":"Michalski","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2024.217324_bib414","doi-asserted-by":"crossref","first-page":"G156","DOI":"10.1152\/ajpgi.2000.278.1.G156","article-title":"A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane","volume":"278","author":"Konig","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217324_bib415","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.canlet.2024.217324_bib416","doi-asserted-by":"crossref","first-page":"G751","DOI":"10.1152\/ajpgi.00330.2018","article-title":"OATP1B3-1B7, a novel organic anion transporting polypeptide, is modulated by FXR ligands and transports bile acids","volume":"317","author":"Malagnino","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"20","key":"10.1016\/j.canlet.2024.217324_bib417","doi-asserted-by":"crossref","first-page":"11092","DOI":"10.1073\/pnas.200325297","article-title":"Alternative splicing of the rat sodium\/bile acid transporter changes its cellular localization and transport properties","volume":"97","author":"Lazaridis","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.canlet.2024.217324_bib418","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep4.1244","article-title":"Placebo-controlled randomized trial of an intestinal bile salt transport inhibitor for pruritus in Alagille syndrome","volume":"2","author":"Shneider","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.canlet.2024.217324_bib419","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-015-0070-9","article-title":"Specific inhibition of bile acid transport alters plasma lipids and GLP-1","volume":"15","author":"Rudling","year":"2015","journal-title":"BMC Cardiovasc Disord."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524007195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524007195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T20:29:36Z","timestamp":1733516976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524007195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":419,"alternative-id":["S0304383524007195"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217324","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring bile acid transporters as key players in cancer development and treatment: Evidence from preclinical and clinical studies","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217324"}}